Alessandra Protti

1.7k total citations
21 papers, 259 citations indexed

About

Alessandra Protti is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Alessandra Protti has authored 21 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Oncology. Recurrent topics in Alessandra Protti's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Cerebral Venous Sinus Thrombosis (4 papers). Alessandra Protti is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Cerebral Venous Sinus Thrombosis (4 papers). Alessandra Protti collaborates with scholars based in Italy, United States and Norway. Alessandra Protti's co-authors include Elio Clemente Agostoni, Roberta Frigerio, Alfonso Ciccone, Sandro Beretta, Ian Galea, Fabio Brusaferri, Claudio Macaluso, Alberto Neri, Enrico Ferrante and Stefano Gandolfi and has published in prestigious journals such as Neurology, Cochrane Database of Systematic Reviews and Journal of the Neurological Sciences.

In The Last Decade

Alessandra Protti

18 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Protti Italy 8 145 83 50 47 43 21 259
Neil Shuey Australia 9 89 0.6× 70 0.8× 21 0.4× 28 0.6× 26 0.6× 22 198
Pavel Hradílek Czechia 9 119 0.8× 138 1.7× 16 0.3× 25 0.5× 27 0.6× 44 277
Gregory Van Stavern United States 8 189 1.3× 93 1.1× 10 0.2× 106 2.3× 40 0.9× 18 311
Byron L. Lam United States 8 151 1.0× 141 1.7× 13 0.3× 111 2.4× 50 1.2× 18 342
Laura Piccolo Italy 11 206 1.4× 169 2.0× 27 0.5× 16 0.3× 29 0.7× 17 378
Keigo Shikishima Japan 10 58 0.4× 48 0.6× 12 0.2× 91 1.9× 34 0.8× 22 225
Shailee Shah United States 9 205 1.4× 56 0.7× 47 0.9× 11 0.2× 8 0.2× 30 297
Elisa Vegezzi Italy 8 112 0.8× 29 0.3× 68 1.4× 9 0.2× 18 0.4× 26 209
Shaoying Tan China 11 102 0.7× 130 1.6× 16 0.3× 174 3.7× 97 2.3× 32 321
K. Rostásy Germany 7 176 1.2× 192 2.3× 41 0.8× 7 0.1× 19 0.4× 11 304

Countries citing papers authored by Alessandra Protti

Since Specialization
Citations

This map shows the geographic impact of Alessandra Protti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Protti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Protti more than expected).

Fields of papers citing papers by Alessandra Protti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Protti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Protti. The network helps show where Alessandra Protti may publish in the future.

Co-authorship network of co-authors of Alessandra Protti

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Protti. A scholar is included among the top collaborators of Alessandra Protti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Protti. Alessandra Protti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gelibter, Stefano, Carlo Salvarani, Davide Filippini, et al.. (2025). Combination therapy with cyclophosphamide, rituximab and corticosteroids in order to arrest a rapidly progressive primary CNS vasculitis: a case report with 40-month follow-up remission. Clinical Neurology and Neurosurgery. 249. 108781–108781.
2.
Gelibter, Stefano, et al.. (2024). Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta‐analysis. European Journal of Neurology. 32(1). e16547–e16547. 3 indexed citations
3.
Gelibter, Stefano, et al.. (2024). As time goes by: Treatment challenges in elderly people with multiple sclerosis. Journal of Neuroimmunology. 391. 578368–578368. 2 indexed citations
4.
Frederiksen, Jette Lautrup, Luca Massacesi, Helle Hvilsted Nielsen, et al.. (2024). Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence study. Multiple Sclerosis and Related Disorders. 93. 106214–106214.
5.
Schwarz, Ghil, Angelo Cascio Rizzo, Guglielmo Pero, et al.. (2024). Exploring thrombus composition in cerebral venous thrombosis: the first case report with initial insights and implications for treatment advancements. Neurological Sciences. 45(5). 2341–2345. 1 indexed citations
6.
Gelibter, Stefano, Fiammetta Pirro, Emanuela Susani, et al.. (2023). Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience. Journal of Neuroimmunology. 383. 578199–578199. 4 indexed citations
7.
Pirro, Fiammetta, et al.. (2022). Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disorders. Multiple Sclerosis Journal. 28(13). 2142–2145. 4 indexed citations
8.
9.
García-Manteiga, José Manuel, Ferdinando Clarelli, Silvia Bonfiglio, et al.. (2021). Identification of differential DNA methylation associated with multiple sclerosis: A family-based study. Journal of Neuroimmunology. 356. 577600–577600. 3 indexed citations
10.
Bignamini, Angelo, L. La Mantia, Maria Grazia Celani, et al.. (2017). Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis. Neurology and Therapy. 6(2). 213–223. 5 indexed citations
11.
Neri, Alberto, et al.. (2015). Dynamic imaging of accommodation by swept-source anterior segment optical coherence tomography. Journal of Cataract & Refractive Surgery. 41(3). 501–510. 39 indexed citations
12.
Neri, Alberto, Alessandra Protti, Monica Camparini, & Claudio Macaluso. (2014). Near-infrared fundus autofluorescence imaging in a case of photic maculopathy. 1(1). 28–28.
13.
Ferrante, Enrico, et al.. (2009). Cerebral Venous Thrombosis Complicating Lumbar Puncture. Headache The Journal of Head and Face Pain. 49(2). 276–277. 8 indexed citations
14.
Ciccone, Alfonso, et al.. (2008). Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database of Systematic Reviews. 2010(1). CD006264–CD006264. 56 indexed citations
15.
Agostoni, Elio Clemente, Roberta Frigerio, & Alessandra Protti. (2005). Controversies in optic neuritis pain diagnosis. Neurological Sciences. 26(S2). s75–s78. 27 indexed citations
16.
Protti, Alessandra, et al.. (2004). Optic neuritis: diagnostic criteria application in clinical practice. Neurological Sciences. 25(S3). s296–s297. 7 indexed citations
17.
Protti, Alessandra, et al.. (2004). An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease. Neurological Sciences. 25(S4). s383–s385. 6 indexed citations
18.
Ferrante, Enrico, et al.. (2004). Spontaneous cerebrospinal fluid leak syndrome: report of 18 cases. Neurological Sciences. 25(S3). s293–s295. 25 indexed citations
19.
Carpo, M., Rosetta Pedotti, S. Allaria, et al.. (1999). Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies. Journal of the Neurological Sciences. 168(2). 78–84. 58 indexed citations
20.
Peluchetti, D., Marina Mora, Alessandra Protti, & F. Cornelio. (1985). Freeze‐fracture analysis of the muscle fiber plasma membrane in Duchenne dystrophy. Neurology. 35(6). 928–928. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Shuey Breakdown of academic impact, for papers by Pavel Hradílek Breakdown of academic impact, for papers by Gregory Van Stavern Breakdown of academic impact, for papers by Byron L. Lam Breakdown of academic impact, for papers by Laura Piccolo Breakdown of academic impact, for papers by Keigo Shikishima Breakdown of academic impact, for papers by Shailee Shah Breakdown of academic impact, for papers by Elisa Vegezzi Breakdown of academic impact, for papers by Shaoying Tan Breakdown of academic impact, for papers by K. Rostásy
Rankless by CCL
2026